The introduction of the 750mcg teriparatide solution in Australia has seen limited distribution to date. Primarily reserved for patients with severe bone loss who have not responded to other treatments , access is selectively managed. Current supply levels are limited, and patients should confirm regarding their specialist the current informatio… Read More